"Goalkeepers" Report About It’s Main Targets, Including HIV

13 September 2017 13:25

The Bill and Melinda Gates Foundation announced the first-annual "Goalkeepers" report — a report about the main targets of the foundation, aimed to improve health care and treatment for the future generations.

HIV is one of the most important areas of the foundation to work on.  According to the actual statistics, published in the buisinessinsider, the HIV rate is   about 0.14 people per 1,000 population, down from a high of 0.30 in the early 2000s. Bill Gates notes, that now people seem feel safe because of many medical developments and progress in HIV treatment over the last decades. Models developed by the Gates Foundation and the Institute for Health Metrics and Evaluation show that a 10% cut in HIV treatment funding could lead to 5.6 million deaths by 2030.

Africa remains in the high risk zone, even with the preservation of HIV funding programs. If  the situation with the medical facilities and health care system remains the same, there is a high risk for more than 250 million people to get HIV-positive status.

"What that means is pretty clear. If we only do as well as we've been doing on prevention, the absolute number of people getting HIV will go up even beyond its previous peak. In the meantime, if we don't spend more to deliver the tools we have now, we'll have more cases. If we have more cases, we'll need to spend more on treatment, or people will die." - Gates comment the release of the foundation.


Share with Telegram

Latest News

New high-quality pill for HIV to be launched in low-and middle-income countries at reduced price

New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price. For about $75, the governments in South Africa and Kenya will soon be able to treat an HIV-infected person for 1 year with a pill taken ...

22 September 14:27

Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report. Training also had a number of beneficial effects, including a significant increase in CD4 cell count and improvements in cholesterol and blood pressure. «The main finding of our study was ...

21 September 13:44

Sanofi tests three-in-one antibody to treat or prevent HIV

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. If all goes well, the three-in-one antibody could be used either as a long-acting treatment or ...

21 September 12:28

By 2020, 70% of people living with HIV in the US will be 50 or older

Due to enormous advances in treatment, people are able to live far longer; so much so that by the year 2020, 70 percent of those living with HIV in the US will be over the age of 50. This is good news, but it brings with it unique complexities. Philanthropic funding is a ...

20 September 14:53